TSE:WELL

WELL Health Technologies (WELL.TO)

4.12
+0.03 (0.73%)
as of Aug 5, 2026, 7:15:36 pm Market Open.
297 watching
0
Investor Insights
star iconAug 5, 2026, 12:00 am

This summary was created by AI, based on 13 opinions in the last 12 months.

WELL Health Technologies is perceived as a company with potential, particularly given its focus on electronic medical records and clinic operations. Reviews highlight a recent struggle with execution, particularly post-pandemic, and frustrations related to acquisitions that haven't significantly moved the stock price. Analysts note a divergent sentiment towards the stock, with many awaiting catalysts for a price rebound, especially as they divest from less favorable US operations. Despite impressive revenue growth signals and an attractive valuation at around 9-10x PE, concerns over competition and regulatory scrutiny remain prevalent, leaving experts in a cautious wait-and-see mode about the company's longer-term prospects.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
KNT, KNT
DON'T BUY
Telemedicine is a very hot space, but can't accept the valuations (he's a value investor). They make good acquisitions. Many revenues come from clinics. All tech companies have sky-high valuations, betting on future sales and earnings. Not for the feint of heart. The valuation is too high.
RISKY

Getting some recognition with digital transformation of health. Had a nice bounce over the last few weeks. More on the risky side. Don't put all your eggs in. One of those names that, if you looked back 10 years from now, might be the next Shopify. Seems to be well run.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. It continues to execute well with a solid management team. The company is well financed and is likely to profit from the expansion of the sector. Growth prospects are positive with committed insiders. Unlock Premium - Try 5i Free

BUY

WELL Health vs. Cloud MD, and buy the warrants? Different companies in the same sector. He owns both and expects both to excel in the coming year. Cloud MD just released earnings, not as strong as he expected, but talked about future catalysts coming in the fall. WELL just announced an acquisition and got financing from their biggest shareholder, Lee Ka-Shing. Both are equally good. Warrants: you could do this, but the challenge is that both stocks have enjoyed huge runs and profit-taking could happen. You have a finite time before those warrants expire worthless or you decide to exercise the warrants--it's riskier, though offers a higher return. In contrast, you can just hold onto the stock.

Showing 76 to 79 of 79 entries